- Home
- GDTC vs GRABW Comparison
GDTC vs GRABW Comparison
Compare GDTC & GRABW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- GRABW
- Stock Information
- Founded
- GDTC 2018
- GRABW N/A
- Country
- GDTC Singapore
- GRABW Singapore
- Employees
- GDTC N/A
- GRABW 10604
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- GRABW Business Services
- Sector
- GDTC Health Care
- GRABW Consumer Discretionary
- Exchange
- GDTC Nasdaq
- GRABW Nasdaq
- Market Cap
- GDTC 18.5M
- GRABW N/A
- IPO Year
- GDTC 2023
- GRABW N/A
- Fundamental
- Price
- GDTC $1.48
- GRABW $0.17
- Analyst Decision
- GDTC Buy
- GRABW
- Analyst Count
- GDTC 1
- GRABW 0
- Target Price
- GDTC $5.00
- GRABW N/A
- AVG Volume (30 Days)
- GDTC 5.5K
- GRABW N/A
- Earning Date
- GDTC 01-01-0001
- GRABW N/A
- Dividend Yield
- GDTC N/A
- GRABW N/A
- EPS Growth
- GDTC N/A
- GRABW N/A
- EPS
- GDTC N/A
- GRABW N/A
- Revenue
- GDTC $384,666.00
- GRABW N/A
- Revenue This Year
- GDTC $4.46
- GRABW N/A
- Revenue Next Year
- GDTC N/A
- GRABW N/A
- P/E Ratio
- GDTC N/A
- GRABW N/A
- Revenue Growth
- GDTC 39.52
- GRABW N/A
- 52 Week Low
- GDTC $1.36
- GRABW N/A
- 52 Week High
- GDTC $5.50
- GRABW N/A
- Technical
- Relative Strength Index (RSI)
- GDTC 39.58
- GRABW 45.78
- Support Level
- GDTC $1.45
- GRABW $0.17
- Resistance Level
- GDTC $1.64
- GRABW $0.18
- Average True Range (ATR)
- GDTC 0.09
- GRABW 0.01
- MACD
- GDTC 0.00
- GRABW 0.00
- Stochastic Oscillator
- GDTC 31.58
- GRABW 32.88
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.